Brecon wins Lilly award

Published: 23-Oct-2006 Featured companies: PCI Pharma Services
Packaging

Pharmaceutical outsource services provider Brecon Pharmaceuticals is the only UK company to have won a 2006 Global Supplier award from global pharma firm Eli Lilly.


Pharmaceutical outsource services provider Brecon Pharmaceuticals is the only UK company to have won a 2006 Global Supplier award from global pharma firm Eli Lilly.

Brecon provides a range of commercial packaging, storage, distribution, analytical and clinical trial services. The Lilly Global Supplier Awards are granted annually in recognition of those suppliers who have demonstrated superior performance and who have assisted the company in sustaining its competitive advantage.

President and md, John Bath, attended the award ceremony at Lilly's US corporate centre in Indianapolis. He was joined by Brecon's customer services manager Neil Lloyd and production supervisor, Karran Alder.

'We are thrilled to have been nominated and to have won a 2006 Lilly Global Supplier award,' Bath said. 'Receiving this prestigious award underscores our absolute commitment to quality and customer service and we were honoured to collect it on behalf of all our team.'

Featured companies

PCI Pharma Services: Your bridge between life-changing therapies and patients.
See more

You may also like

Packaging

Essential elements of package design and artwork creation for commercial success

Read more
Designing a product’s packaging and artwork is often perceived as a last hurdle … and a relatively minor detail in the complex journey to commercialisation

Trending Articles

  1. ProMach Pharma presents new equipment at Pack Expo Las Vegas Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
  2. Aenova Group In Europe and worldwide, Aenova is one of the leading contract development and manufacturing organisations (CDMO). The range of services covers the entire value chain of development and production of all common dosage forms (solid, semi-solid and liquid, sterile and non-sterile; high potency and low dosage) and product groups in drugs and food supplements for human and animal health
  3. Intranasal GLP-1 medication from Orexo shows positive results in preclinical trial Orexo's AmorphOX technology had positive results when compared against oral and injectable formulations in the study
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    From approval to access: the strategic role of packaging in drug launch success In today’s increasingly complex pharmaceutical landscape, securing regulatory approval is only one milestone on the journey to market
  5. SGD Pharma acquires Alphial Srl in a strategic step forward SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules headquartered in Italy

Relevant companies

See more

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Packaging

Essential elements of package design and artwork creation for commercial success

Designing a product’s packaging and artwork is often perceived as a last hurdle … and a relatively minor detail in the complex journey to commercialisation
Distribution

CDMOs deliver increased performance for pharma clients with agility and innovation

Emma Verkaik, Membership & Marketing Director at the BCMPA — the Association for Contract Manufacturing, Packing, Fulfilment & Logistics — gleans insights from members in the pharma sector regarding emerging trends, growth opportunities and the impact of increasing digitalisation, sustainability issues and ESG on the wider industry
Manufacturing

Biologics and specialty medicines: planning your packaging from clinic to launch (part I)

The pharmaceutical landscape continues to evolve with an ever-increasing focus on specialty medicines. As a result, supply chains are becoming more elaborate, driven by factors such as cold and ultra-cold chain requirements, the growing complexity of delivery systems and the ever more stringent regulatory requirements associated with the packaging of such products
Design & Build

PCI invests in high-speed automation

Global outsourcing partner has made a multimillion dollar investment to expand centre of excellence and packaging capabilities
Manufacturing

PCI expands in Canada with clinical trial services acquisition

Bellwyck Pharma Services has joined US-based PCI’s global network
Packaging

PCI adds 30,000 sqft to Illinois site

The US outsourcing provider’s Clinical Center of Excellence in Rockford expansion is aiming to increase primary and secondary packaging, labelling, and 2-8°C cold chain storage capabilities
Packaging

PCI invests in bottling line expansion

Illinois commercial packaging site has received investment to add nearly 100 million units of bottling line capacity
Subscribe now